# COBRA PZF™ Coronary Stent for Early Healing, Thrombus Inhibition, Endothelialization and Avoiding Long-Term DAPT

> **NCT01925794** · NA · COMPLETED · sponsor: **CeloNova BioSciences, Inc.** · enrollment: 296 (actual)

## Conditions studied

- Coronary Artery Disease

## Interventions

- **DEVICE:** COBRA PzF

## Key facts

- **NCT ID:** NCT01925794
- **Lead sponsor:** CeloNova BioSciences, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-08-21
- **Primary completion:** 2015-11
- **Final completion:** 2020-03-02
- **Target enrollment:** 296 (ACTUAL)
- **Last updated:** 2021-12-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01925794

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01925794, "COBRA PZF™ Coronary Stent for Early Healing, Thrombus Inhibition, Endothelialization and Avoiding Long-Term DAPT". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01925794. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*